Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients. - Wikidata - awgldk - TriplyDB

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.

http://www.wikidata.org/entity/Q36925337

about

Oncolytic viruses as therapeutic cancer vaccines Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer Going viral: a review of replication-selective oncolytic adenoviruses Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances Adenovirus vectors for gene therapy, vaccination and cancer gene therapy Trial Watch:: Oncolytic viruses for cancer therapy Oncolytic viruses as anticancer vaccines Targeting autophagy to sensitive glioma to temozolomide treatment Trial Watch-Oncolytic viruses and cancer therapy Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity.The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells Oncolytic immunotherapy: where are we clinically?Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.Oncolytic adenoviruses: A thorny path to glioma cure Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.Combinatorial strategies for the induction of immunogenic cell death.T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer.MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation Emerging immunotherapies for glioblastoma Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment.Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies The role and therapeutic potential of autophagy modulation in controlling virus-induced cell death.Oncolytic viruses and their application to cancer immunotherapy Metronomics: towards personalized chemotherapy?Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.The role of oncolytic virus immunotherapies to subvert cancer immune evasion.Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma.The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model.Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.

P2860

Q21245758-A017A5D4-BDA8-4950-A5F9-C3C2D42D2020 Q26795466-62853551-3729-419E-B0A4-81A80B0C9E46 Q26797520-BAC2F2C0-BF73-4106-A48E-1663F18CBF11 Q26863779-2EF2FFDF-3528-430A-AED4-5D622ACE9899 Q27001601-CC707AC3-7DD8-44DD-ACA0-E095C27EA2AD Q27021951-78D15B70-B6BB-4752-A707-B10D67451131 Q27025600-BB507A1A-E445-4F95-8A7B-D02FC3B263DA Q28066270-72E3C9C3-0FA0-4D1F-856B-3264551E58AA Q28072347-3D1D3D2D-F5B5-43D0-825D-B2EB99675685 Q28072922-A05A3FEC-A730-4A6D-BA28-83B60D4A41F2 Q30899557-DB8199E3-12BE-4951-AE2C-DAE983136EAB Q33633272-A0CB57AF-CD38-4B02-97FE-F90624A4F287 Q33670728-34130EA8-1DC7-462A-861B-EB62682E7E6C Q33844943-4ED8A9CD-4D84-43C5-B306-772DC2824C61 Q34076586-D0F01B0F-E27C-4049-9265-520268E96CE8 Q34405325-FD50D7DE-09D2-4420-A89B-F12E3EF8648C Q34426949-8114EA6A-673C-410F-AFD0-DBE2256703EB Q35077747-66692038-0F23-4A96-AE0B-F1F406DB2D55 Q35506253-F86F5995-47FE-422F-B07F-349DCE2A3F68 Q35535140-C2371FCC-6042-4460-BB56-53CF575FDA2A Q35594838-6D692F9D-BA1B-4125-97C3-8F5492E8D534 Q35653264-D003BD55-DF4C-40FF-B0C9-4BD5F6B92B93 Q35657822-A8091CDA-C755-4BEB-BCEE-358AF4659646 Q36372763-2F0364A5-3C7F-4227-8361-F84137E1E86A Q36710972-5684342C-358B-46E8-8D6A-CCDCF26DB25C Q36808390-503BDD8A-2E64-4C25-AE2B-7573ABC8232C Q37025105-435E786D-7CAD-4CF5-A559-5C52F8BDDBD6 Q37152107-EB33956F-971D-4CE9-A127-2998DD1C9597 Q37158473-6CE8C3E3-7D8E-48EF-AE28-53702D021BAB Q37707676-622AC217-1B60-416D-953B-36921B84D542 Q38139255-94B3B9D5-95CA-492E-9211-85EA7FB5F4AB Q38152376-576CAB3B-0A7D-472E-91E4-1826B4E36707 Q38207011-7486ABE9-6062-42E0-844A-754A22DD0081 Q38218923-59F8C827-9AEB-4F0E-B156-02D439CB66E5 Q38237657-820E7D0A-E0AB-4B67-8DE1-D70C39B31BED Q38295771-F1C9799D-3BAD-4BBF-9B6E-ECDE086DF28A Q38357137-288A7540-9AB9-4E60-9916-F1665796845B Q38534285-7B26A3A8-872E-4683-8789-8564BFEB3B74 Q38598702-40F1694A-A623-46FD-BE05-9A09D4818DFF Q38715077-7F6A5FF0-E6A5-42DA-B707-4488CC2B8F20

P2860

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.

http://www.wikidata.org/entity/Q36925337

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Oncolytic adenovirus with temo ...... responses in cancer patients.

@en

type

label

Oncolytic adenovirus with temo ...... responses in cancer patients.

@en

prefLabel

Oncolytic adenovirus with temo ...... responses in cancer patients.

@en

P1433

Q36925337-820D8F91-5FEB-4EB3-A826-9B52F414B7CB

P1476

Q36925337-3655E3BE-6524-4631-A720-788AE3660662

P2093

Q36925337-003CEEEA-6134-46B7-8778-7129A66FEE3B

Q36925337-0A1726B8-A07E-42D3-B729-AFE0E2763D79

Q36925337-0F6B78C6-B52A-4790-B2CB-02CC65AF3DC4

Q36925337-25F2529A-7FD7-447E-B0A6-20F5F87B5D52

Q36925337-317787F9-4B5F-4D9A-9294-6B5E144905D3

Q36925337-45DCDEE7-2610-4352-9555-0B22A4A411CD

Q36925337-6B0F394D-95E9-46FE-834E-C779472BA1D2

Q36925337-86159444-AA04-478A-8FEB-36386128CFD1

Q36925337-8BF0E932-26B6-4885-8A58-F95222140894

Q36925337-8EE3C424-D86C-4CD6-9C93-4E74FE90AFC5

P2860

Q36925337-02795F3C-FB71-44F3-BDB8-BB1B279B8712

Q36925337-064B1C83-9008-45AB-B8FE-CC53801285D5

Q36925337-1BB3EF42-D4BF-436D-81C9-02A58666F9C1

Q36925337-1D9EF65F-392F-4811-8C79-DF9B2EF01ECD

Q36925337-2B568F7B-1884-420F-9D6A-2244809B316A

Q36925337-2E11657E-35E9-4D51-B7DE-32D7E420338F

Q36925337-3604D982-3475-495A-B664-59BDC3418F97

Q36925337-36B0E44D-D620-41B2-8944-C1835F74CDEE

Q36925337-3D19E7DE-57D2-4F19-92EA-E0E19D42C357

Q36925337-4E8CCF41-87A9-4154-BDF6-1862D8FF07BF

P304

Q36925337-39624841-1325-4416-A616-27B9AC3209BD

P31

Q36925337-9565326B-40D5-4B29-9B57-90F43027B0EA

P356

Q36925337-F3E9AB4F-301D-402A-9569-4E640AFCCF2B

P433

Q36925337-B63D1BB2-7050-4BCC-B14C-7D4AD990A0BF

P478

Q36925337-BB1C63B7-CC1F-4E5B-A486-3CB4C74A4487

P50

Q36925337-5F01BEB1-4887-4FD7-B520-6F418AC36DC8

Q36925337-8B1955DA-3CE8-4DC4-AC13-D0CD0FDE4B8E

Q36925337-92F3BF03-07D7-482B-BE0D-B1D9396CA699

Q36925337-D5D9CC8C-CA90-4C45-930F-497B1FEFB5A0

Q36925337-DFF4FF86-B788-497E-9493-52F922BFC5D1

P577

Q36925337-D6B15C69-6F5B-498C-9A6F-EE0B179F71CB

P5875

Q36925337-B63F3DDA-C8E7-436B-A16F-4710D71237F2

P698

Q36925337-5CB6D1B6-8EB8-48EF-AD00-57B5E8EBF051

P921

Q36925337-618848A5-F192-422D-B416-A70CE3E236F3

Q36925337-811E7D02-A0E9-4D2D-87FE-19EEE6B8B09E

Q36925337-8B198F33-AA9B-40CE-839F-257B121745E0

P932

Q36925337-7426AF8A-1F00-49CB-9FEB-2F61BF141A5F

P356

P1433

Molecular Therapy

P1476

Oncolytic adenovirus with temo ...... responses in cancer patients.

@en

P2093

Anniina Koski

http://www.w3.org/2001/XMLSchema#string

Fang Zhao

http://www.w3.org/2001/XMLSchema#string

Ilkka Liikanen

http://www.w3.org/2001/XMLSchema#string

Kaarina Partanen

http://www.w3.org/2001/XMLSchema#string

Laura Ahtiainen

http://www.w3.org/2001/XMLSchema#string

Leena Laasonen

http://www.w3.org/2001/XMLSchema#string

Lotta Kangasniemi

http://www.w3.org/2001/XMLSchema#string

Mari L M Hirvinen

http://www.w3.org/2001/XMLSchema#string

Otto Hemminki

http://www.w3.org/2001/XMLSchema#string

Petri Nokisalmi

http://www.w3.org/2001/XMLSchema#string

P2860

Intelligent design: combination therapy with oncolytic viruses

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

Drug combination studies and their synergy quantification using the Chou-Talalay method

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors.

Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro.

Immunogenic and tolerogenic cell death.

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

P304

1212-1223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2013.51

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Akseli Hemminki

P577

2013-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236097485

http://www.w3.org/2001/XMLSchema#string

P698

23546299

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3681222

http://www.w3.org/2001/XMLSchema#string